These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 32561857)

  • 21. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
    de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
    J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.
    Liu P; Hong Y; Yang B; Shrestha P; Sajjad N; Chen JL
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32961897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cis-acting function for the coronavirus leader in defective interfering RNA replication.
    Chang RY; Hofmann MA; Sethna PB; Brian DA
    J Virol; 1994 Dec; 68(12):8223-31. PubMed ID: 7966615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages.
    Volk A; Hackbart M; Deng X; Cruz-Pulido Y; O'Brien A; Baker SC
    J Virol; 2020 May; 94(11):. PubMed ID: 32188729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. THE PECULIARITY OF COVID- 19 GENOME AND THE CORONAVIRUS RNA TRANSLATION PROCESS AS APOTENTIAL TARGET FOR ETIOTROPIC MEDICATIONSWITH ADENINE AND OTHER NUCLEOTIDE ANALOGUES (REVIEW).
    Ratiani L; Gegechkory S; Machavariani K; Shotadze T; Sanikidze T; Intskirveli N
    Georgian Med News; 2021 Jan; (310):119-124. PubMed ID: 33658420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective Packaging in Murine Coronavirus Promotes Virulence by Limiting Type I Interferon Responses.
    Athmer J; Fehr AR; Grunewald ME; Qu W; Wheeler DL; Graepel KW; Channappanavar R; Sekine A; Aldabeeb DS; Gale M; Denison MR; Perlman S
    mBio; 2018 May; 9(3):. PubMed ID: 29717007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biogenesis and architecture of arterivirus replication organelles.
    van der Hoeven B; Oudshoorn D; Koster AJ; Snijder EJ; Kikkert M; Bárcena M
    Virus Res; 2016 Jul; 220():70-90. PubMed ID: 27071852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADP-ribose-1"-monophosphatase: a conserved coronavirus enzyme that is dispensable for viral replication in tissue culture.
    Putics A; Filipowicz W; Hall J; Gorbalenya AE; Ziebuhr J
    J Virol; 2005 Oct; 79(20):12721-31. PubMed ID: 16188975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The current landscape of coronavirus-host protein-protein interactions.
    Perrin-Cocon L; Diaz O; Jacquemin C; Barthel V; Ogire E; Ramière C; André P; Lotteau V; Vidalain PO
    J Transl Med; 2020 Aug; 18(1):319. PubMed ID: 32811513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of host proteins composing the microenvironment of coronavirus replicase complexes by proximity-labeling.
    V'kovski P; Gerber M; Kelly J; Pfaender S; Ebert N; Braga Lagache S; Simillion C; Portmann J; Stalder H; Gaschen V; Bruggmann R; Stoffel MH; Heller M; Dijkman R; Thiel V
    Elife; 2019 Jan; 8():. PubMed ID: 30632963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
    Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
    Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Coronaviruses].
    Taguchi F
    Uirusu; 2011 Dec; 61(2):205-10. PubMed ID: 22916567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.
    Grunewald ME; Chen Y; Kuny C; Maejima T; Lease R; Ferraris D; Aikawa M; Sullivan CS; Perlman S; Fehr AR
    PLoS Pathog; 2019 May; 15(5):e1007756. PubMed ID: 31095648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common RNA replication signals exist among group 2 coronaviruses: evidence for in vivo recombination between animal and human coronavirus molecules.
    Wu HY; Guy JS; Yoo D; Vlasak R; Urbach E; Brian DA
    Virology; 2003 Oct; 315(1):174-83. PubMed ID: 14592769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Yeast Suppressor Screen Used To Identify Mammalian SIRT1 as a Proviral Factor for Middle East Respiratory Syndrome Coronavirus Replication.
    Weston S; Matthews KL; Lent R; Vlk A; Haupt R; Kingsbury T; Frieman MB
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31142674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical aspects of coronavirus replication and virus-host interaction.
    Enjuanes L; Almazán F; Sola I; Zuñiga S
    Annu Rev Microbiol; 2006; 60():211-30. PubMed ID: 16712436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of coronavirus RNA capping and methylation.
    Chen Y; Guo D
    Virol Sin; 2016 Feb; 31(1):3-11. PubMed ID: 26847650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular biology of coronaviruses.
    Masters PS
    Adv Virus Res; 2006; 66():193-292. PubMed ID: 16877062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors.
    Hackbart M; Deng X; Baker SC
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8094-8103. PubMed ID: 32198201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.